Patent classifications
A01N65/28
APPARATUS AND METHOD FOR PROTECTING AGAINST MICROBIAL HAZARDS
An antimicrobial material that includes an antimicrobial layer comprising an antimicrobial agent entrapped within a polymer matrix is provided. The polymer matrix is water stable, and an exposed surface of the antimicrobial layer exhibits sustained-release antimicrobial properties for at least 7 days. A composition for forming the antimicrobial material is also provided, as well as, a method of making the antimicrobial material.
APPARATUS AND METHOD FOR PROTECTING AGAINST MICROBIAL HAZARDS
An antimicrobial material that includes an antimicrobial layer comprising an antimicrobial agent entrapped within a polymer matrix is provided. The polymer matrix is water stable, and an exposed surface of the antimicrobial layer exhibits sustained-release antimicrobial properties for at least 7 days. A composition for forming the antimicrobial material is also provided, as well as, a method of making the antimicrobial material.
INSECT REPELLING COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF
Insect-repelling compositions comprise from about 0.001% to about 10% by weight of plant essential oils. The balance of the composition to 100% by weight includes deionized water, vanillin powder, isopropanol, glycerin, an emulsifier (such as polyglycerol oleate and/or sodium lauryl sulfate), and an aqueous chitosan formulation. The chitosan formulation comprises ≤8% volume of chitosan and ≤8% volume of acetic acid or vinegar.
INSECT REPELLING COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF
Insect-repelling compositions comprise from about 0.001% to about 10% by weight of plant essential oils. The balance of the composition to 100% by weight includes deionized water, vanillin powder, isopropanol, glycerin, an emulsifier (such as polyglycerol oleate and/or sodium lauryl sulfate), and an aqueous chitosan formulation. The chitosan formulation comprises ≤8% volume of chitosan and ≤8% volume of acetic acid or vinegar.
INSECT REPELLING COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF
Insect-repelling compositions comprise from about 0.001% to about 10% by weight of plant essential oils. The balance of the composition to 100% by weight includes deionized water, vanillin powder, isopropanol, glycerin, an emulsifier (such as polyglycerol oleate and/or sodium lauryl sulfate), and an aqueous chitosan formulation. The chitosan formulation comprises ≤8% volume of chitosan and ≤8% volume of acetic acid or vinegar.
FUNGICIDAL MIXTURES
The present invention provides improved combinations, mixtures and compositions comprising a phthalimide fungicide and a primary fungicide, as well as methods of use and processes of preparation thereof.
FUNGICIDAL MIXTURES
The present invention provides improved combinations, mixtures and compositions comprising a phthalimide fungicide and a primary fungicide, as well as methods of use and processes of preparation thereof.
Non-toxic larvicide
A larvicide comprising an essential oil encapsulated within a non-viable yeast cell. The larvicide is particularly effective against mosquito larvae, non-toxic to humans and other non-target species, inexpensive to make, and non-toxic during manufacture, transport, and storage.
Non-toxic larvicide
A larvicide comprising an essential oil encapsulated within a non-viable yeast cell. The larvicide is particularly effective against mosquito larvae, non-toxic to humans and other non-target species, inexpensive to make, and non-toxic during manufacture, transport, and storage.
Method of treatment using a biocidal or phytoprotective product, device and corresponding treatment assembly
A method of treatment with at least one biocidal and/or safener product with a boiling temperature between 60 and 280° C., wherein the method comprises a treatment step duration greater than or equal to 3 days, wherein the treatment step comprises at least one injection phase of a duration greater than or equal to 3 days during which a liquid containing the, or each, product is evaporated and injected inside an enclosure, wherein the liquid is evaporated and injected with a period of less than or equal to two days during the injection phase, wherein the liquid is evaporated at a temperature below 50° C.